Grifols

Grifols is a pharmaceutical company founded in 1940. The company is primarily focused on the development and manufacturing of plasma-derived therapies, vaccines, and hospital pharmacy products. Grifols has been particularly active in the treatment of rare and chronic diseases such as immune deficiencies, genetic emphysema, and other conditions related to the immune system. They also offer a variety of diagnostic products and services for the healthcare industry.